From patient to paper: how tumour donations help Crick scientists understand cancer

Mike Malley, 72, was diagnosed with a type of kidney cancer called renal cell carcinoma in February 2015. Whilst undergoing treatment, he signed up to a Cancer Research UK funded study called TRACERx (Tracking Cancer Evolution through therapy) Renal that looks at the evolution of kidney cancer to try and better predict tumour behaviour, in the hope of improving treatments in the future.

To highlight the critical role of patients in clinical research, we invited Mike to the Crick to meet some of the scientists working on the TRACERx Renal project - an ongoing collaboration between scientists and clinicians from the Crick, UCL, The Royal Marsden and Guy’s and St Thomas’.

To find out more about TRACERx visit: http://tracerx.co.uk/
More information about the PEACE trial can be found here: http://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-study-looking-at-blood-and-tissue-samples-to-learn-more-about-advanced-cancer-peace

To find out more about Crick research, go to our website: https://www.crick.ac.uk/
Follow us on Twitter: https://twitter.com/TheCrick
Find us on Facebook: https://www.facebook.com/TheFrancisCr...

This video was made by Greta Keenan.

Видео From patient to paper: how tumour donations help Crick scientists understand cancer канала Francis Crick Institute